Multiorgan Outcomes Following BNT162b2 mRNA Vaccination vs SARS-CoV-2 Infection: A 30-Million-Person Real-World Cohort Analysis.
COVID-19 vaccination reduced heart-related deaths by 77% and major cardiovascular events by 65-76% compared to infection, confirming strong cardiac protection beyond preventing the virus itself.
SARS-CoV-2 infection caused 3-5x increases in acute cardiovascular events (myocarditis, mortality) persisting beyond 9 months; BNT162b2 conferred 65-76% MACE reductions; two-dose series reduced mortality by 77% vs. unvaccinated.
What the study was
- Study design
- retrospective_cohort
- Category
- sentinel
- Maturity
- Validated
- Journal
- NPJ Vaccines
Why it surfaced
Largest real-world cohort (30M persons) quantifying cardiovascular risk-benefit of BNT162b2 vs. COVID-19 infection; directly actionable for population cardiovascular risk stratification.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.